• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glenmark Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20600.0
  • ISIN : INE935A01035
2,145.30 1 (0.05%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    2,132.00

  • Today’s High

    2,166.10

  • Open

    2,145.00

  • Perv Close

    2,144.20

  • 52W Low

    1,275.50

  • 52W High

    2,284.80

Key Indicators

  • P/E(TTM)

    34.69

  • Mar.Cap (₹Cr.)

    60,540.54

  • Div & Yield %

    0.12

  • Book Value(₹)

    868.32

  • Debt-Equity Ratio

    0.05

  • AGM Date

    25-Jul-2025

  • EPS

    61.81

  • P/E Ratio

    34.69

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    60,540.54

  • RONW (%)

    -50.87

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    28.22

  • BV (₹)

    868.30

  • Sales( ₹ in Cr.)

    9,010.54

  • NP (in Cr.)

    1,744.30

  • NP Var(%)

    22.0

  • Div%

    250.0

  • CPS (₹)

    69.60

  • EPS (₹)

    61.80

  • Traded Value (₹ in Lakhs)

    60,513.73

  • 52 Week High

    2,284.80

  • 52 Week Low

    1,275.50

  • Price BSE

    2144.0

  • Price NSE

    2,145.00

  • Market Capital( in Cr.)

    60,513.73

  • P/C Ratio

    30.80

  • P/E Ratio

    34.70

  • Price Vs.BV

    61.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Other Income 6,238.36 985.94 1,044.96 470.13 625.34 954.61
Stock Adjustments 103.07 31.37 16.13 -5.24 -48.77 -471.81
Total Income 14,232.55 9,237.97 9,202.67 8,032.82 7,289.20 6,787.67
EXPENDITURE :            
Raw Materials 3,313.19 3,427.07 3,474.66 2,944.53 2,617.22 1,887.15
Power and Fuel Cost 104.92 95.09 91.34 80.49 90.76 82.99
Employee Cost 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Other Manufacturing Expenses 375.32 304.66 297.44 267.26 230.03 218.75
Selling and Administration Expenses 1,199.17 1,246.10 1,062.89 914.37 977.77 992.83
Miscellaneous Expenses 325.15 855.71 349.97 358.30 371.53 353.89
Employee Benefit Expenses 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,752.52 7,275.13 6,469.50 5,672.35 5,359.63 4,505.58
Operating Profit 7,480.02 1,962.84 2,733.18 2,360.47 1,929.57 2,282.08
Interest 277.11 206.82 236.04 265.90 256.39 223.81
Gross Profit 7,202.91 1,756.02 2,497.14 2,094.57 1,673.18 2,058.27
Depreciation 202.16 184.15 159.70 150.82 138.54 106.28
Profit Before Tax 7,000.75 1,571.87 2,337.44 1,943.75 1,534.64 1,951.99
Current Tax 1,049.99 386.93 411.08 343.62 269.24 383.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 783.46 -23.83 -71.42 -49.31 -89.14 -53.61
Reported Net Profit 5,167.29 1,208.77 1,997.79 1,649.45 1,354.55 1,622.11
Extraordinary Items 3,742.26 -369.56 354.02 59.87 14.43 277.16
Adjusted Net Profit 1,425.03 1,578.33 1,643.77 1,589.58 1,340.12 1,344.95
Adjustment below Net Profit -4.76 0.63 1.61 2.48 -5.42 -3.54
P & L Balance brought forward 16,002.82 14,863.96 12,921.86 11,340.47 10,059.38 8,508.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 77.22 70.54 57.30 70.54 68.03 68.03
P & L Balance carried down 21,088.13 16,002.82 14,863.96 12,921.86 11,340.47 10,059.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 250.00 250.00 250.00 250.00 200.00
Dividend Per Share(Rs) 2.50 2.50 2.50 2.50 2.50 2.00
Earnings Per Share-Unit Curr 183.11 42.84 70.80 58.46 48.00 57.49
Earnings Per Share(Adj)-Unit Curr 183.11 42.84 70.80 58.46 48.00 57.49
Book Value 814.01 633.57 593.21 524.84 468.73 423.22
Book Value(Adj)-Unit Curr 814.01 633.57 593.21 524.84 468.73 423.22

Shareholding Pattern

  • Promoter Group

    46.65%

  • Public Share Holding

    53.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,391,001 1.20 3,391,001 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128,241,936 45.44 128,241,936 1
Others 0 0.00 0 0
Sub Total 131,632,937 46.65 131,632,937 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 107,631 0.04 107,631 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,240 0.00 1,240 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 58,203,030 20.62 58,203,030 324
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,293,429 0.46 1,293,429 15
Mutual Funds / UTI 43,884,095 15.55 43,884,095 30
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,592,876 1.63 4,592,876 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 108,082,301 38.30 108,082,301 396
2] Non Institution
Bodies Corporate 6,456,262 2.29 6,456,262 1,008
Clearing Members 5,507 0.00 5,507 7
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,155,276 0.76 2,151,276 4,740
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 537,473 0.19 537,473 3,317
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,040,796 3.91 10,440,796 15
Individuals holding nominal share capital up to Rs. 1 lakh 21,938,631 7.77 21,711,297 180,705
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 60,956 0.02 60,956 13
Others 290,670 0.10 290,670 3
Sub Total 42,485,571 15.06 41,654,237 189,808
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,200,809 100.00 281,369,475 190,210

Company Background

Glenmark Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Glenmark Pharmaceuticals Ltd
  • BSE Code : 20600.0
  • ISIN : INE935A01035

  • Incorporation Year

    1977

  • Registered Office

    B/2 Mahalaxmi Chambers
    22 Bhulabhai Desai Road, Mumbai,
    Maharashtra-400026

  • Telephone

    91-22-40189999

  • FAX

    91-22-40189986

  • Chairman

    Glenn Saldanha

  • Managing Director

    Glenn Saldanha

  • Company Secretary

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glenmark Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glenmark Pharma. 2,144.35 9,059.14 7,891.12 37.58 9.75
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10